EP Patent
EP1611879A1 — Use of emulsions for intra- and periocular injection
Assigned to Novagali SA · Expires 2006-01-04 · 20y expired
What this patent protects
Use of a composition comprising an emulsion and optionally at least a pharmaceutical active ingredient for the manufacture of a medicament in a form adapted for intra- and periocular administration.
USPTO Abstract
Use of a composition comprising an emulsion and optionally at least a pharmaceutical active ingredient for the manufacture of a medicament in a form adapted for intra- and periocular administration.
Drugs covered by this patent
- Sandimmune (cyclosporine) · Novartis AG (originally Sandoz)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.